The Safety of Hyperbaric Oxygen Therapy in the Treatment of Covid-19

Relevance. Acute respiratory infection COVID-19 caused by the SARS-CoV-2 (2019-nCov) coronavirus is severe and extremely severe in 15—20% of cases, which is accompanied by the need for respiratory support. Hyperbaric oxygenation is recognized as an effective therapy for replenishing any form of oxyg...

Full description

Saved in:
Bibliographic Details
Main Authors: O. A. Levina, A. K. Еvseev, A. K. Shabanov, V. V. Kulabukhov, N. Y. Kutrovskaya, I. V. Goroncharovskaya, K. A. Popugaev, D. A. Kosolapov, D. S. Slobodeniuk, S. S. Petrikov
Format: Article
Language:Russian
Published: Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department 2020-10-01
Series:Неотложная медицинская помощь
Subjects:
Online Access:https://www.jnmp.ru/jour/article/view/923
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849699796645838848
author O. A. Levina
A. K. Еvseev
A. K. Shabanov
V. V. Kulabukhov
N. Y. Kutrovskaya
I. V. Goroncharovskaya
K. A. Popugaev
D. A. Kosolapov
D. S. Slobodeniuk
S. S. Petrikov
author_facet O. A. Levina
A. K. Еvseev
A. K. Shabanov
V. V. Kulabukhov
N. Y. Kutrovskaya
I. V. Goroncharovskaya
K. A. Popugaev
D. A. Kosolapov
D. S. Slobodeniuk
S. S. Petrikov
author_sort O. A. Levina
collection DOAJ
description Relevance. Acute respiratory infection COVID-19 caused by the SARS-CoV-2 (2019-nCov) coronavirus is severe and extremely severe in 15—20% of cases, which is accompanied by the need for respiratory support. Hyperbaric oxygenation is recognized as an effective therapy for replenishing any form of oxygen debt.Aim of study. To study the safety of HBO use in patients with COVID-19.Material and metods. We examined 32 patients with the diagnosis “Coronavirus infection caused by the virus SARS-CoV-2” (10 — moderately severe patients (CT 1–2), 22 — patients in serious condition (CT 3–4), who received course of hyperbaric oxygenation (HBO). The procedures were carried out in a Sechrist 2800 chamber (USA) at a mode of 1.4–1.6 AT for no more than 60 minutes. In total, the patients received 141 HBO sessions. Before and after each HBO session, the subjective indicators of the patient’s condition were assessed and the blood oxygen saturation was measured.Results. An algorithm for HBO course management was developed, which consists in using “soft” modes (up to 1.4 AT) during the first session, followed by pressure adjustment (not higher than 1.6 AT) during the course to achieve maximum therapeutic effect and comfort for the patient. Against the background of the HBO course, the patients showed an increase in blood oxygen saturation in patients in both surveyed groups, as well as positive dynamics in the form of a decrease in shortness of breath, an improvement in general well-being.Conclusion. The inclusion of daily sessions (at least 4) of hyperbaric oxygenation in “soft” modes (1.4–1.6 ATA) in the complex therapy for COVID-19 has shown its safety and preliminary positive effect on the subjective state of the examined patients and the dynamics of blood oxygen saturation.
format Article
id doaj-art-3eb50f0b43924c15b2a32d0ce2259be4
institution DOAJ
issn 2223-9022
2541-8017
language Russian
publishDate 2020-10-01
publisher Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
record_format Article
series Неотложная медицинская помощь
spelling doaj-art-3eb50f0b43924c15b2a32d0ce2259be42025-08-20T03:18:30ZrusSklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare DepartmentНеотложная медицинская помощь2223-90222541-80172020-10-019331432010.23934/2223-9022-2020-9-3-314-320590The Safety of Hyperbaric Oxygen Therapy in the Treatment of Covid-19O. A. Levina0A. K. Еvseev1A. K. Shabanov2V. V. Kulabukhov3N. Y. Kutrovskaya4I. V. Goroncharovskaya5K. A. Popugaev6D. A. Kosolapov7D. S. Slobodeniuk8S. S. Petrikov9General Resuscitation Department N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health DepartmentGeneral Resuscitation Department N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health DepartmentGeneral Resuscitation Department N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health DepartmentGeneral Resuscitation Department N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health DepartmentGeneral Resuscitation Department N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health DepartmentGeneral Resuscitation Department N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health DepartmentGeneral Resuscitation Department N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health DepartmentGeneral Resuscitation Department N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health DepartmentGeneral Resuscitation Department N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health DepartmentGeneral Resuscitation Department N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health DepartmentRelevance. Acute respiratory infection COVID-19 caused by the SARS-CoV-2 (2019-nCov) coronavirus is severe and extremely severe in 15—20% of cases, which is accompanied by the need for respiratory support. Hyperbaric oxygenation is recognized as an effective therapy for replenishing any form of oxygen debt.Aim of study. To study the safety of HBO use in patients with COVID-19.Material and metods. We examined 32 patients with the diagnosis “Coronavirus infection caused by the virus SARS-CoV-2” (10 — moderately severe patients (CT 1–2), 22 — patients in serious condition (CT 3–4), who received course of hyperbaric oxygenation (HBO). The procedures were carried out in a Sechrist 2800 chamber (USA) at a mode of 1.4–1.6 AT for no more than 60 minutes. In total, the patients received 141 HBO sessions. Before and after each HBO session, the subjective indicators of the patient’s condition were assessed and the blood oxygen saturation was measured.Results. An algorithm for HBO course management was developed, which consists in using “soft” modes (up to 1.4 AT) during the first session, followed by pressure adjustment (not higher than 1.6 AT) during the course to achieve maximum therapeutic effect and comfort for the patient. Against the background of the HBO course, the patients showed an increase in blood oxygen saturation in patients in both surveyed groups, as well as positive dynamics in the form of a decrease in shortness of breath, an improvement in general well-being.Conclusion. The inclusion of daily sessions (at least 4) of hyperbaric oxygenation in “soft” modes (1.4–1.6 ATA) in the complex therapy for COVID-19 has shown its safety and preliminary positive effect on the subjective state of the examined patients and the dynamics of blood oxygen saturation.https://www.jnmp.ru/jour/article/view/923coronavirus infectioncovid-19hyperbaric oxygenationhypoxiahypoxemiarespiratory support
spellingShingle O. A. Levina
A. K. Еvseev
A. K. Shabanov
V. V. Kulabukhov
N. Y. Kutrovskaya
I. V. Goroncharovskaya
K. A. Popugaev
D. A. Kosolapov
D. S. Slobodeniuk
S. S. Petrikov
The Safety of Hyperbaric Oxygen Therapy in the Treatment of Covid-19
Неотложная медицинская помощь
coronavirus infection
covid-19
hyperbaric oxygenation
hypoxia
hypoxemia
respiratory support
title The Safety of Hyperbaric Oxygen Therapy in the Treatment of Covid-19
title_full The Safety of Hyperbaric Oxygen Therapy in the Treatment of Covid-19
title_fullStr The Safety of Hyperbaric Oxygen Therapy in the Treatment of Covid-19
title_full_unstemmed The Safety of Hyperbaric Oxygen Therapy in the Treatment of Covid-19
title_short The Safety of Hyperbaric Oxygen Therapy in the Treatment of Covid-19
title_sort safety of hyperbaric oxygen therapy in the treatment of covid 19
topic coronavirus infection
covid-19
hyperbaric oxygenation
hypoxia
hypoxemia
respiratory support
url https://www.jnmp.ru/jour/article/view/923
work_keys_str_mv AT oalevina thesafetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT akevseev thesafetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT akshabanov thesafetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT vvkulabukhov thesafetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT nykutrovskaya thesafetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT ivgoroncharovskaya thesafetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT kapopugaev thesafetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT dakosolapov thesafetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT dsslobodeniuk thesafetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT sspetrikov thesafetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT oalevina safetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT akevseev safetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT akshabanov safetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT vvkulabukhov safetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT nykutrovskaya safetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT ivgoroncharovskaya safetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT kapopugaev safetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT dakosolapov safetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT dsslobodeniuk safetyofhyperbaricoxygentherapyinthetreatmentofcovid19
AT sspetrikov safetyofhyperbaricoxygentherapyinthetreatmentofcovid19